Literature DB >> 24158983

Nurse practitioner care improves renal outcome in patients with CKD.

Mieke J Peeters1, Arjan D van Zuilen, Jan A J G van den Brand, Michiel L Bots, Marjolijn van Buren, Marc A G J Ten Dam, Karin A H Kaasjager, Gerry Ligtenberg, Yvo W J Sijpkens, Henk E Sluiter, Peter J G van de Ven, Gerald Vervoort, Louis-Jean Vleming, Peter J Blankestijn, Jack F M Wetzels.   

Abstract

Treatment goals for patients with CKD are often unrealized for many reasons, but support by nurse practitioners may improve risk factor levels in these patients. Here, we analyzed renal endpoints of the Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of Nurse Practitioners (MASTERPLAN) study after extended follow-up to determine whether strict implementation of current CKD guidelines through the aid of nurse practitioners improves renal outcome. In total, 788 patients with moderate to severe CKD were randomized to receive nurse practitioner support added to physician care (intervention group) or physician care alone (control group). Median follow-up was 5.7 years. Renal outcome was a secondary endpoint of the MASTERPLAN study. We used a composite renal endpoint of death, ESRD, and 50% increase in serum creatinine. Event rates were compared with adjustment for baseline serum creatinine concentration and changes in estimated GFR were determined. During the randomized phase, there were small but significant differences between the groups in BP, proteinuria, LDL cholesterol, and use of aspirin, statins, active vitamin D, and antihypertensive medications, in favor of the intervention group. The intervention reduced the incidence of the composite renal endpoint by 20% (hazard ratio, 0.80; 95% confidence interval, 0.66 to 0.98; P=0.03). In the intervention group, the decrease in estimated GFR was 0.45 ml/min per 1.73 m(2) per year less than in the control group (P=0.01). In conclusion, additional support by nurse practitioners attenuated the decline of kidney function and improved renal outcome in patients with CKD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158983      PMCID: PMC3904557          DOI: 10.1681/ASN.2012121222

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  UK Renal Registry 12th Annual Report (December 2009): chapter 10: biochemistry profile of patients receiving dialysis in the UK in 2008: national and centre-specific analyses.

Authors:  Anne Dawnay; Ken Farrington; Clare Castledine; Dirk van Schalkwyk; Graham Warwick
Journal:  Nephron Clin Pract       Date:  2010-03-31

3.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Authors:  Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

4.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Authors:  Dick de Zeeuw; Rajiv Agarwal; Michael Amdahl; Paul Audhya; Daniel Coyne; Tushar Garimella; Hans-Henrik Parving; Yili Pritchett; Giuseppe Remuzzi; Eberhard Ritz; Dennis Andress
Journal:  Lancet       Date:  2010-11-06       Impact factor: 79.321

5.  A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial.

Authors:  Brendan J Barrett; Amit X Garg; Ron Goeree; Adeera Levin; Anita Molzahn; Claudio Rigatto; Joel Singer; George Soltys; Steven Soroka; Dieter Ayers; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

6.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

7.  Nurse practitioners improve quality of care in chronic kidney disease: two-year results of a randomised study.

Authors:  A D van Zuilen; P J Blankestijn; M van Buren; M A G J ten Dam; K A H Kaasjager; G Ligtenberg; Y W J Sijpkens; H E Sluiter; P J G van de Ven; G Vervoort; L Vleming; M L Bots; J F M Wetzels
Journal:  Neth J Med       Date:  2011 Nov-Dec       Impact factor: 1.422

8.  [Treatment of patients with chronic renal insufficiency; a guideline for internists].

Authors:  P M ter Wee; A T Jorna
Journal:  Ned Tijdschr Geneeskd       Date:  2004-04-10

9.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

10.  Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.

Authors:  Pantaleo Giannuzzi; Pier Luigi Temporelli; Roberto Marchioli; Aldo Pietro Maggioni; Gianluigi Balestroni; Vincenzo Ceci; Carmine Chieffo; Marinella Gattone; Raffaele Griffo; Carlo Schweiger; Luigi Tavazzi; Stefano Urbinati; Franco Valagussa; Diego Vanuzzo
Journal:  Arch Intern Med       Date:  2008-11-10
View more
  34 in total

1.  Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.

Authors:  Sankar D Navaneethan; Stacey E Jolly; Jesse D Schold; Susana Arrigain; Georges Nakhoul; Victoria Konig; Jennifer Hyland; Yvette K Burrucker; Priscilla Davis Dann; Barbara H Tucky; John Sharp; Joseph V Nally
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 8.237

2.  Evaluating risk of ESRD in the urban poor.

Authors:  Marlena Maziarz; R Anthony Black; Christine T Fong; Jonathan Himmelfarb; Glenn M Chertow; Yoshio N Hall
Journal:  J Am Soc Nephrol       Date:  2014-12-04       Impact factor: 10.121

3.  Person-Centered Integrated Care for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Pim P Valentijn; Fernando Abdalla Pereira; Marinella Ruospo; Suetonia C Palmer; Jörgen Hegbrant; Christina W Sterner; Hubertus J M Vrijhoef; Dirk Ruwaard; Giovanni F M Strippoli
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-09       Impact factor: 8.237

Review 4.  Effectiveness of Quality Improvement Strategies for the Management of CKD: A Meta-Analysis.

Authors:  Samuel A Silver; Chaim M Bell; Glenn M Chertow; Prakesh S Shah; Kaveh Shojania; Ron Wald; Ziv Harel
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-06       Impact factor: 8.237

5.  The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease (PSP-CKD) Study: A Cluster Randomized Trial in Primary Care.

Authors:  Rupert W Major; Celia Brown; David Shepherd; Stephen Rogers; Warren Pickering; Graham L Warwick; Shaun Barber; Nuzhat B Ashra; Tom Morris; Nigel J Brunskill
Journal:  J Am Soc Nephrol       Date:  2019-05-16       Impact factor: 10.121

6.  Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial.

Authors:  Kassia S Beetham; Rathika Krishnasamy; Tony Stanton; Julian W Sacre; Bettina Douglas; Nicole M Isbel; Jeff S Coombes; Erin J Howden
Journal:  J Am Soc Nephrol       Date:  2021-12-10       Impact factor: 10.121

7.  Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.

Authors:  Brendon L Neuen; Hocine Tighiouart; Hiddo J L Heerspink; Edward F Vonesh; Juhi Chaudhari; Shiyuan Miao; Tak Mao Chan; Fernando C Fervenza; Jürgen Floege; Marian Goicoechea; William G Herrington; Enyu Imai; Tazeen H Jafar; Julia B Lewis; Philip Kam-Tao Li; Francesco Locatelli; Bart D Maes; Ronald D Perrone; Manuel Praga; Annalisa Perna; Francesco P Schena; Christoph Wanner; Jack F M Wetzels; Mark Woodward; Di Xie; Tom Greene; Lesley A Inker
Journal:  J Am Soc Nephrol       Date:  2021-12-03       Impact factor: 10.121

Review 8.  Value-Based Care and Kidney Disease: Emergence and Future Opportunities.

Authors:  Sri Lekha Tummalapalli; Mallika L Mendu
Journal:  Adv Chronic Kidney Dis       Date:  2022-01       Impact factor: 4.305

9.  Effectiveness and acceptability of a multidisciplinary approach in improving the care of patients with advanced chronic kidney disease: a pilot study.

Authors:  Jia Liang Kwek; Konstadina Griva; Navreen Kaur; Kay Yuan Chong; Zi Yang Chua; Gim Hong Andy Sim; Li Choo Ng; Pay Wen Yong; Yu-Tzu Tung; Lydia Wei Wei Lim; Su Hooi Teo; Jason Chon Jun Choo; Marjorie Wai Yin Foo; Tazeen Hasan Jafar
Journal:  Int Urol Nephrol       Date:  2021-07-22       Impact factor: 2.370

10.  Sufficiency of Knowledge Processed in Patient Education in Dialysis Care.

Authors:  Saija Inkeroinen; Jenni Koskinen; Mia Karlsson; Taina Kilpi; Helena Leino-Kilpi; Pauli Puukka; Ros-Marie Taponen; Riitta Tuominen; Heli Virtanen
Journal:  Patient Prefer Adherence       Date:  2021-05-27       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.